HERV-K is transiently reactivated in early human development to protect cells from the threat of exogenous viral infection (10); however, HERV-K retrotransposition entails a risk of genomic impairment in SOX2-expressing cells, such as iPSCs. Here, SOX2 is linked to viral infectious disease.